Disclosures none Nilsson E, Gasparini A, Arnlov J, Xu H, - - PowerPoint PPT Presentation

disclosures
SMART_READER_LITE
LIVE PREVIEW

Disclosures none Nilsson E, Gasparini A, Arnlov J, Xu H, - - PowerPoint PPT Presentation

To do or not to do? Pro /Con Debate on Hyperkalemia for the Elective Cataract Patient By: Melissa Kreso Associate Professor of Anesthesiology & Perioperative Medicine Ophthalmic Anesthesia Society September 2018 Disclosures none


slide-1
SLIDE 1

To do or not to do?

Pro/Con Debate on

Hyperkalemia for the Elective Cataract Patient

By: Melissa Kreso Associate Professor of Anesthesiology & Perioperative Medicine Ophthalmic Anesthesia Society September 2018

slide-2
SLIDE 2

Disclosures

none

slide-3
SLIDE 3

Incidence of Hyperkalemia?

  • Nilsson E, Gasparini A,

Arnlov J, Xu H, Henriksson KM, Coresh J, Grams ME, Carrero JJ. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J

  • f Card 2017; 245:277-

84.

slide-4
SLIDE 4

Incidence of Hyperkalemia?

  • Nilsson E, Gasparini A,

Arnlov J, Xu H, Henriksson KM, Coresh J, Grams ME, Carrero JJ. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J

  • f Card 2017; 245:277-

84.

365,955 people

slide-5
SLIDE 5

Incidence of Hyperkalemia?

  • Nilsson E, Gasparini A,

Arnlov J, Xu H, Henriksson KM, Coresh J, Grams ME, Carrero JJ. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J

  • f Card 2017; 245:277-

84.

Number of People K+ wnl K+ >5.0 mmol/L

slide-6
SLIDE 6

Incidence of Hyperkalemia?

  • Nilsson E, Gasparini A,

Arnlov J, Xu H, Henriksson KM, Coresh J, Grams ME, Carrero JJ. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J

  • f Card 2017; 245:277-

84.

Number of People K+ wnl K+>5.0mmol/L K+ >5.5 mmol/L

slide-7
SLIDE 7

Factors for having hyperkalemia

  • Nilsson E, Gasparini A,

Arnlov J, Xu H, Henriksson KM, Coresh J, Grams ME, Carrero JJ. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J of Card 2017; 245:277-84.

slide-8
SLIDE 8

Factors for having hyperkalemia

  • Nilsson E, Gasparini A,

Arnlov J, Xu H, Henriksson KM, Coresh J, Grams ME, Carrero JJ. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J of Card 2017; 245:277-84.

slide-9
SLIDE 9

What does this mean for outcomes?

slide-10
SLIDE 10

What does these mean on

  • utcomes?

The influence of potassium disorders especially hyperkalemia on outcomes has not been established

slide-11
SLIDE 11

Potassium & Arrhythmias

Intraoperative dysrhythmias correlated with preoperative dysrhythmias If present, there was a higher incidence intraop But NOT correlated to HIGH potassium levels

Vitez TS, Soper LE, Wong KC, Soper P. Chronic hypokalemia and Intraoperative

  • Dysrhythmias. Anesthesiology 1985; 63:

130-3.

slide-12
SLIDE 12

Absence of adverse

  • utcomes?
  • Olson RP, Schow AJ,

McCann R, Lubarsky DA, Gan TJ. Absence of adverse outcomes in hyperkalemic patients undergoing vascular access surgery. Can J Anesth 2003; 50(6): 553-7.

slide-13
SLIDE 13

Absence of adverse

  • utcomes?
  • Olson RP, Schow AJ,

McCann R, Lubarsky DA, Gan TJ. Absence of adverse outcomes in hyperkalemic patients undergoing vascular access surgery. Can J Anesth 2003; 50(6): 553-7.

slide-14
SLIDE 14

Absence of adverse

  • utcomes?
  • Olson RP, Schow AJ,

McCann R, Lubarsky DA, Gan TJ. Absence of adverse outcomes in hyperkalemic patients undergoing vascular access surgery. Can J Anesth 2003; 50(6): 553-7.

People going for vascular surgery

potassium <5 mmol/L potassium>5 mmol/L

slide-15
SLIDE 15

People going for vascular surgery

potassium <5 mmol/L potassium>5 mmol/L

Absence of adverse

  • utcomes?
  • Olson RP, Schow AJ,

McCann R, Lubarsky DA, Gan TJ. Absence of adverse outcomes in hyperkalemic patients undergoing vascular access surgery. Can J Anesth 2003; 50(6): 553-7.

slide-16
SLIDE 16

Absence of adverse

  • utcomes?
  • Olson RP, Schow AJ,

McCann R, Lubarsky DA, Gan TJ. Absence of adverse outcomes in hyperkalemic patients undergoing vascular access surgery. Can J Anesth 2003; 50(6): 553-7.

No Adverse Outcomes!

slide-17
SLIDE 17

Risk of serious arrhythmias

Hirsch IA, Tomlinson DL, et al. The overstated risk of preoperative hypokalemia. Anesth Analg 1988; 67(2):131-6.

slide-18
SLIDE 18

Risk of serious arrhythmias

  • Cardiac/Vascular surgery
  • Associated with
  • Hx of CHF
  • Ventricular aneurysm
  • Digoxin usage

Hirsch IA, Tomlinson DL, et al. The overstated risk of preoperative hypokalemia. Anesth Analg 1988; 67(2):131-6.

slide-19
SLIDE 19

Risk of serious arrhythmias

  • Cardiac/Vascular surgery
  • Associated with
  • Hx of CHF
  • Ventribular aneurysm
  • Digoxin usage
  • BUT NOT
  • Potassium nor

diuretic usage

Hirsch IA, Tomlinson DL, et al. The overstated risk of preoperative hypokalemia. Anesth Analg 1988; 67(2):131-6.

slide-20
SLIDE 20

Another study

  • Retrospective review
  • 1861 patients with CRF

for 8456 surgeries

  • 13 (2%) had potassiums >

6.0 mEq/L immediately prior to surgery

  • 17 had potassiums

>6.5mEq/L within 6M of having surgery (which were not repeated)

  • Underwent planned
  • perations
  • No difference in adverse

events amongst patients

Ehrenfeld JM, Sedykh A, Furman W,. Management of Potassium abnormalities on the day of Surgery: A Retrospective Review. (A1652) Abstract presented at ASA Annual Meeting; 2011 Chicago, IL

slide-21
SLIDE 21

Does ROC rock?

  • 61 patient
  • Sux group vs rocuronium-

suggamadex group

  • Median time
  • 406 seconds to spon vent,

sux group

  • 216 seconds to spon vent,

roc-sugga group

  • Median time TOF 90

recovery

  • 518s with sux
  • 168s with roc-suga

Sorensen MK, Bretlau C, Gatke MR, Sorensen AM, Rasmussen LS. Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine: a randomized

  • trial. BJA 2012; 108(4): 682-9
slide-22
SLIDE 22

Does ROC rock?

Sorensen MK, Bretlau C, Gatke MR, Sorensen AM, Rasmussen LS. Rapid sequence induction and intubation with rocuronium- sugammadex compared with succinylcholine: a randomized trial. BJA 2012; 108(4): 682-9

slide-23
SLIDE 23

Does ROC rock?

  • Rapid sequence induction

with rocuronium f/b sugammadex = earlier re- establishment of spontaneous ventilation than with succinylcholine alone!

Sorensen MK, Bretlau C, Gatke MR, Sorensen AM, Rasmussen LS. Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine: a randomized trial. BJA 2012; 108(4): 682-9